Concepedia
Statistics
Publications
7
Citations
330
H-Index
Active since
2015
Affiliations
University of Toronto(Current)
Lunenfeld-Tanenbaum Research Institute
Ontario Institute for Cancer Research
Mount Sinai Hospital
Hospital for Sick Children
Rosemarie E. Venier is an author at University of Toronto specializing in molecular oncology, oncology, and medicine.
Publications per year
2015–2022
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations
Anita Villani, Scott Davidson, Nisha Kanwar et al. · Nature Cancer · 2022 · 127 citations · Full text
Medicine, Genetics, Oncology +17
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
Nathaniel D. Anderson, Yael Babichev, Fabio Fuligni et al. · Nature Communications · 2021 · 64 citations · Full text
PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma
Yael Babichev, Leah Kabaroff, Alessandro Datti et al. · Journal of Translational Medicine · 2016 · 53 citations · Full text
Medicine, Oncology, Pharmacology +17
Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma
Timothy McKinnon, Rosemarie E. Venier, Marielle E. Yohe et al. · Oncogene · 2018 · 49 citations · Full text
Medicine, Cancer Biology, Oncology +16
BRCA1-Associated RING Domain-1 (BARD1) Loss and GBP1 Expression Enhance Sensitivity to DNA Damage in Ewing Sarcoma
Lisa M. Maurer, Jessica D. Daley, Elina Mukherjee et al. · Cancer Research Communications · 2022 · 16 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
1–5 of 7